These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1235 related items for PubMed ID: 19409728

  • 1. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH, Wang-Chesebro A, Weinberg V, Pouliot J, Chen LM, Speight J, Littell R, Hsu IC.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1329-34. PubMed ID: 19409728
    [Abstract] [Full Text] [Related]

  • 2. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL, Weinberg V, Chen LM, Littell R, Cunha JAM, Sethi RA, Chan JK, Hsu IC.
    Int J Radiat Oncol Biol Phys; 2015 Aug 01; 92(5):1093-1100. PubMed ID: 26194683
    [Abstract] [Full Text] [Related]

  • 3. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 01; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

  • 4. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K, Murayama S.
    Gynecol Oncol; 2005 Mar 01; 96(3):665-70. PubMed ID: 15721409
    [Abstract] [Full Text] [Related]

  • 5. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
    J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643
    [Abstract] [Full Text] [Related]

  • 6. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e49-56. PubMed ID: 21470794
    [Abstract] [Full Text] [Related]

  • 7. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up.
    Pötter R, Dimopoulos J, Bachtiary B, Sissolak G, Klos B, Rheinthaller A, Kirisits C, Knocke-Abulesz TH.
    Radiother Oncol; 2006 Apr 01; 79(1):80-6. PubMed ID: 16516316
    [Abstract] [Full Text] [Related]

  • 8. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD, Rai B, Mallick I, Sharma SC.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):125-30. PubMed ID: 15850912
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
    Narayan K, van Dyk S, Bernshaw D, Rajasooriyar C, Kondalsamy-Chennakesavan S.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1529-35. PubMed ID: 19473780
    [Abstract] [Full Text] [Related]

  • 10. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K, Jassem J.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):814-21. PubMed ID: 15465198
    [Abstract] [Full Text] [Related]

  • 11. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 01; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 12. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC, Ho ES, Jan JS, Yang CH, Liu FS.
    Gynecol Oncol; 1996 Apr 01; 61(1):101-8. PubMed ID: 8626094
    [Abstract] [Full Text] [Related]

  • 13. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C.
    Radiother Oncol; 2007 May 01; 83(2):148-55. PubMed ID: 17531904
    [Abstract] [Full Text] [Related]

  • 14. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093
    [Abstract] [Full Text] [Related]

  • 15. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S, Bhatnagar A, Heron DE, Selvaraj R, Mogus R, Kim H, Gerszten K, Kelley J, Edwards RP.
    Brachytherapy; 2006 Dec 01; 5(4):218-22. PubMed ID: 17118313
    [Abstract] [Full Text] [Related]

  • 16. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K, Gallop-Evans E, Hanna L, Adams M.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):140-6. PubMed ID: 18922646
    [Abstract] [Full Text] [Related]

  • 17. Anatomy-based inverse planning dose optimization in HDR prostate implant: a toxicity study.
    Mahmoudieh A, Tremblay C, Beaulieu L, Lachance B, Harel F, Lessard E, Pouliot J, Vigneault E.
    Radiother Oncol; 2005 Jun 01; 75(3):318-24. PubMed ID: 16086913
    [Abstract] [Full Text] [Related]

  • 18. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
    Kazumoto T, Kato S, Tabushi K, Kutsutani-Nakamura Y, Mizuno H, Takahashi M, Shiromizu K, Saito Y.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1157-66. PubMed ID: 17459604
    [Abstract] [Full Text] [Related]

  • 19. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
    Sakata K, Sakurai H, Suzuki Y, Katoh S, Ohno T, Toita T, Kataoka M, Tanaka E, Kaneyasu Y, Uno T, Harima Y, Nakano T, Japan Radiation Oncology Study Group.
    Acta Oncol; 2008 Nov 15; 47(3):434-41. PubMed ID: 18348003
    [Abstract] [Full Text] [Related]

  • 20. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.